Article Versions Notes

Dent S, Fergusson D, Aseyev O, Stober C, Pond G, Awan AA, McGee SF, Ng TL, Simos D, Vandermeer L, et al. A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer. Current Oncology. 2021; 28(6):5073-5083. https://doi.org/10.3390/curroncol28060427

Dent, Susan, Dean Fergusson, Olexiy Aseyev, Carol Stober, Gregory Pond, Arif A. Awan, Sharon F. McGee, Terry L. Ng, Demetrios Simos, Lisa Vandermeer, and et al. 2021. "A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer" Current Oncology 28, no. 6: 5073-5083. https://doi.org/10.3390/curroncol28060427

Dent, S., Fergusson, D., Aseyev, O., Stober, C., Pond, G., Awan, A. A., McGee, S. F., Ng, T. L., Simos, D., Vandermeer, L., Saunders, D., Hilton, J. F., Hutton, B., & Clemons, M., on behalf of the REaCT Investigators. (2021). A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer. Current Oncology, 28(6), 5073-5083. https://doi.org/10.3390/curroncol28060427